Le Lézard
Classified in: Health
Subjects: RCL, PSF

Advisory - Health Canada warns of three DigitDots magnet sets that pose serious risks


OTTAWA, ON, May 12, 2022 /CNW/ - 

Summary

Product: DigitDots 3 mm and 5 mm Magnetic Balls
Issue: These magnet sets are small enough to be swallowed, posing serious and potentially life-threatening risks.
What to do: Immediately stop using these products, check that all pieces are accounted for, and dispose of them.

Issue

Health Canada is warning Canadians of the serious danger posed by DigitDots magnet sets that were sold to Canadians online by HD Premier.

These sets contain small, powerful magnets that can be easily swallowed by children of all ages, posing serious and potentially life-threatening risks.  

When more than one powerful magnet is swallowed in a short period of time, the magnets can attract one another while moving through the intestines. This can cause the intestines to twist, creating blockages or tearing of the intestinal walls. Swallowing more than one magnet can damage gastrointestinal tissues and can require emergency surgical treatment, resulting in possible long-term health effects and even death.

What consumers should do
What Health Canada is doing

Health Canada has determined that these small powerful magnet sets are prohibited because they are a danger to human health and safety under the Canada Consumer Product Safety Act (CCPSA). They exceed the maximum allowable limit of magnetic force and pose an ingestion hazard.

These products have been removed from sale from HD Premier's website. The foreign company has voluntarily recalled (English only) the affected products in the United States. Health Canada has contacted the foreign company and is advising Canadians to immediately stop using these magnet sets and to be careful with other magnet sets purchased in stores or online. Health Canada also suggests Canadians learn about the risks of buying consumer products online (see Related Links below). 

To date, no incidents or injuries related to these products have been reported to Health Canada.

Health Canada is committed to helping protect Canadians from potentially dangerous consumer products. The Department regularly tests consumer products available for sale to Canadians in stores or online and continues to monitor products to help keep consumers safe.

Product affected

3mm Multi-Color DigitDots (CNW Group/Health Canada)

5mm Silver DigitDots (CNW Group/Health Canada)

5mm Multi-Color DigitDots (CNW Group/Health Canada)

Report health or safety concerns:

Health Canada would like to remind Canadians to report any health or safety incidents related to the use of this product or any other consumer product or cosmetic by filling out the Consumer Product Incident Report Form.

Related links

Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today that four abstracts with Innate's drug candidates have been accepted for the European Association of Hematology (EHA) 2024 Congress,...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for Heart Failure to its discovery portfolio...

at 00:01
America's child care supply remains flat, while child care prices continue to increase, according to a new report released today by Child Care Aware® of America (CCAoA) that highlights the burden families face accessing quality and affordable child...

at 00:01
The cost of living is Gen Zs' and millennials' top societal concern, but green shoots of optimism for the economy and their personal finances are emergingNearly nine in 10 Gen Zs and millennials say purpose is important to their job satisfaction and...

at 00:00
AmacaThera Inc, a clinical stage biotechnology company specializing in the development of advanced sustained release hydrogel formulations, has dosed its first human subject with AMT-143, the company's lead asset in non-opioid acute pain management. ...

14 mai 2024
BioArctic AB's (publ) partner Eisai today said that they expect Leqembi sales to total JPY 56.5 billion (approximately SEK 4 billion) for their fiscal year (FY) 2024 (April 2024 through March 2025). This would generate approximately SEK 360 M in net...



News published on and distributed by: